Details for Patent: 8,778,365
Which drugs does patent 8,778,365 protect, and when does it expire?
Patent 8,778,365 protects NAFTIN and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 8,778,365
| Title: | Topical compositions and methods for making and using same |
| Abstract: | The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof. |
| Inventor(s): | Bhushan Hardas, Donna Dalton |
| Assignee: | Sebela Ireland Ltd |
| Application Number: | US13/756,392 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,778,365 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 8,778,365
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Legacy | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 204286-001 | Jun 27, 2013 | AB | RX | Yes | Yes | 8,778,365 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,778,365
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014212201 | ⤷ Start Trial | |||
| Canada | 2899725 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2014121048 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
